We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Drug Shows Promise in Preventing Restenosis

By Biotechdaily staff writers
Posted on 11 Jun 2002
A new drug has shown the ability in animals to prevent macrophages from accumulating in arteries treated by angioplasty, thereby preventing new blockages from occurring in the arteries.

Macrophages are sent to a blocked area after angioplasty to help the area heal. More...
In many cases, as many as 30-40%, the accumulation of macrophages in this area causes a new blockage to form. The new drug, designed to prevent this restenosis, is applied prior to angioplasty. The drug consists of nano-sized liposomes, each containing a molecule that is toxic to macrophages. Since the macrophages do not recognize that the vesicles contain a toxic molecule, they ingest the vesicles, causing the macrophages to die. To date, the drug has been used successfully to treat rats, pigs, and rabbits. Clinical trials are expected to begin this year.

The medication operates like a Trojan horse, explained Prof. Gershon Golomb, chairman of the School of Pharmacy at the Hebrew University of Jerusalem (Israel), who designed the new medication. For his work, Prof. Gershon received a Kaye Award. The Kaye Innovations Awards at Hebrew University were established to encourage faculty, staff, and students of the university to develop innovative methods and inventions with good commercial potential that will benefit the university and society.




Related Links:
Hebrew Univ.

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Clinical Informatics Platform
CLARION™
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.